National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

interferon alfacon-1
An analogue of consensus interferon which contains an additional methionyl amino acid residue. Consensus interferon (also known as interferon alfacon-1, rCon-IFN, and CIFN) is a genetically engineered synthetic interferon created from the most common amino acid sequences from the naturally occurring alpha interferons. Alpha interferons bind to specific cell-surface receptors, resulting in the transcription and translation of genes whose protein products have antiviral, antiproliferative, anticancer, and immune-modulating effects. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:consensus interferon
IFN Alfacon-1
Interferon Consensus, Methionyl
interferon consensus, methionyl
methionyl interferon consensus
methionyl-interferon-consensus
Recombinant Consensus Interferon
Recombinant methionyl human consensus interferon
US brand name:Infergen
Foreign brand name:Advaferon
Abbreviations:CIFN
r-metHuIFN-Con1



Previous:INO-1001, inosine dialdehyde, inositol, inotuzumab ozogamicin, integrin-targeted immunoconjugate IMGN388
Next:interleukin-12 gene, interleukin-2 gene, interleukin-2 liposome, IntraDose, intranasal ketamine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov